Clinical trials
Phase 1 Basal Cell Carcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
46 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2004 | 2 |
| 2006 | 1 |
| 2008 | 4 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 4 |
| 2019 | 6 |
| 2020 | 3 |
| 2021 | 3 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 29 |
| Recruiting | 5 |
| Unknown status | 5 |
| Terminated | 4 |
| Active, not recruiting | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Case Comprehensive Cancer Center | 3 |
| Novartis Pharmaceuticals | 3 |
| Jean Yuh Tang | 2 |
| Roswell Park Cancer Institute | 2 |
| Shahid Beheshti University of Medical Sciences | 2 |
| Bispebjerg Hospital | 1 |
| Blaze Bioscience Australia Pty Ltd | 1 |
| Bristol-Myers Squibb | 1 |
| Center for Biomedical Research, Inc. | 1 |
| CivaTech Oncology | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Basal Cell Carcinoma | 46 |
| Skin Neoplasms | 12 |
| Cutaneous Squamous Cell Carcinoma | 8 |
| Melanoma | 8 |
| Carcinoma, Merkel Cell | 5 |
| Carcinoma, Squamous Cell | 5 |
| Breast Neoplasms | 4 |
| Lymphoma | 4 |
| Lymphoma, T-Cell, Cutaneous | 4 |
| Medulloblastoma | 4 |
Trials
Showing 51 to 46 of 46. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.